Key terms

About ALEC

Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies. Its treatment targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA.

Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest ALEC news

Mar 21 4:12pm ET Alector Inc Announces Board Retirement and New Members Mar 07 12:06am ET Alector’s Clinical Progress and Financial Health Anchor Buy Recommendation Feb 29 6:40am ET Analysts Offer Insights on Healthcare Companies: DocGo (DCGO), Revance Therapeutics (RVNC) and Alector (ALEC) Feb 28 7:38am ET Optimistic Buy Rating for Alector’s AL002 Based on Promising Alzheimer’s Disease Trial Biomarkers and TREM2 Signaling Efficacy Feb 28 5:37am ET Alector: Cautious Hold Rating Ahead of Key Clinical Trial Milestones and Financial Assessment Feb 28 3:37am ET Alector (ALEC) Receives a Buy from Barclays Feb 27 7:05pm ET TD Cowen Sticks to Their Buy Rating for Alector (ALEC) Feb 27 4:27pm ET Alector reports Q4 EPS (49c), consensus (77c) Feb 13 5:27am ET Analysts Offer Insights on Healthcare Companies: Healthequity (HQY), Alector (ALEC) and Cytokinetics (CYTK) Feb 13 5:23am ET Alector’s Promising Pipeline and Market Potential Affirm Buy Rating Feb 08 8:01pm ET Analysts Offer Insights on Healthcare Companies: Alector (ALEC), Viking Therapeutics (VKTX) and Zimmer Biomet Holdings (ZBH) Feb 08 7:12am ET Alector announces first patient dosed in PROGRESS-AD Phase 2 trial Feb 07 7:08am ET Alector, GSK announce FDA granted BTD to latozinemab Jan 20 3:00am ET Alector Inc Announces $75 Million Stock Offering Deal Jan 17 9:10am ET Alector $75M Spot Secondary priced at $6.90 Jan 17 8:58am ET Alector announces pricing of $75M public offering of common stock Jan 16 4:01pm ET Alector announces common stock offering, no amount given Jan 07 5:27am ET Alector (ALEC) Gets a Buy from BTIG Jan 02 9:09am ET Alector (ALEC) Gets a Buy from BTIG Dec 31 5:07am ET Alector (ALEC) Gets a Buy from BTIG

No recent news articles are available for ALEC

No recent press releases are available for ALEC

ALEC Financials

1-year income & revenue

Key terms

ALEC Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

ALEC Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms